Ipamorelin Science: Mechanism, Research & Studies
Ipamorelin is a selective growth hormone-releasing peptide (GHRP) studied for its targeted secretagogue activity with minimal impact on cortisol or prolactin in research models.
Mechanism of action
Ipamorelin is investigated in growth research pathways. In laboratory models it is studied for its interactions with the cellular signaling and receptor systems relevant to growth hormone secretagogue.
Research benefits
- Selective ghrelin/GHS-R agonist
- Frequently paired with CJC-1295 in research
- Short pulse-style release profile
Selected studies & citations
Preclinical evaluation of Ipamorelin
In-vitro and animal-model research examining gh secretion pulse studies and downstream signaling.
Peer-reviewed preclinical literature
Dose-response characterization
Concentration-dependent effects of Ipamorelin on cellular endpoints under controlled laboratory conditions.
Published in-vitro studies
Safety & handling
Ipamorelin is sold strictly for laboratory research. Handle with standard laboratory precautions and follow published safety data.